We screened 349 isolates of P. aeruginosa from cystic fibrosis (CF+) and non-cystic fibrosis (CF-) patients for the auxotrophy. Fourteen (4.0%) were auxotrophic and among them only one was recovered from CFpatient showing that this characteristic is strongly associated with cystic fibrosis. In total, a requirement for 5 different compounds (or combination) was verified and, of these, methionine was the most common single amino acid required. Only one auxotrophic isolate was no able to produce biofilm in vitro.
persist in this environment. Some isolates of P. aeruginosa from patients with CF also have specific nutritional requirements and they are called auxotrophic because of their inability to grow in a basic medium containing mineral salts and glucose as the sole carbon source (3).
Generally, P. aeruginosa from clinical and environmental sources are prototrophic, but approximately half of CF patients colonized with P. aeruginosa are harboring isolates that require the provision of specific factors for growth (3, 4) . The most common nutritional requirement of these auxotrophic isolates is methionine, but other amino acids such as leucine, arginine, or ornithine may also be required by a minority of isolates.
Sometimes, auxotrophic isolates are also found in patients with bronchiectasis, but they have not been isolated from patients with other conditions (1) . Difficulty for eradication and antimicrobial resistance are characteristics presented by auxotrophic isolates that have been related to its easy adaptation inside lung with CF and the ability to produce biofilm (1).
The aim of the study presented here was to evaluate the nutritional requirement for P. aeruginosa isolates recovered from sputa and endotracheal aspirate of CF+ and CF-patients.
Furthermore, we evaluated the ability of biofilm production for the auxotrophic isolates. The ability to produce biofilm for the auxotrophic isolates was determined by microtiter plate assay according to the protocol previously described (5).
Of the 349 isolates evaluated, 14 (4%) were auxotrophic.
Among these auxotrophic isolates, only one isolate were recovered from a CF-patient. Table shows that among the 14 auxotrophic strains identified, the most common single amino acid required was methionine (8 isolates), followed by arginine and asparagine (2 isolates each). One isolate grew only on a combination of alanine and proline, and other required a combination of methionine, cysteine and threonine (Table 1) .
Because the presence of some amino acids are required in order to allow the growth of auxotrophic isolate, it is possible that these amino acids are present in the airways of CF patients. P.
aeruginosa wild-type are nutritionally versatile. Thus, we speculate that this would be the original mode of the respiratory tract colonization and that wild-type isolate would be substituted by its auxotrophic variants during the infection process (3). The selection process of auxotrophic isolates in the lung is not clear; however it is known to be a bacterial strategy to prevent the waste of energy through downregulation of a metabolic way, in view to reduce the production of some substances freely present in the environment. Synthesis of amino acid is energetically expensive and bacteria with loss of ability to produce some amino acid would have metabolic and energetic advantages (7) .
Some studies have shown that auxotrophic P. aeruginosa isolates are highly associated with acute exacerbations of respiratory infection in CF patients (2, 3, 4) , and that these isolates are often more resistant to antimicrobial agents than prototrophic wild-type isolates (2). This antimicrobial resistance can be explained, in part, due to the biofilm production, once that there is a microenvironment in the CF lung that permit the ideal condition for the biofilm formation.
Indeed, in our study, thirteen of the 14 auxotrophic strains presented weak-(10 isolates) and moderate-(3 isolates) biofilm production in vitro ( In this study, the most required amino acids were methionine and arginine, which were previously reported as the most common ones for the auxotrophic isolates (1, 4) . High level serum of the key-precursor of methionine, called sulphadenosylmethionone, is verified in CF patients (6) . Thus, methionine synthetase inhibitors and antimicrobial therapy together could be useful for the treatment of these patients (6).
To our knowledge, this is the first description of auxotrophy phenomenon among Brazilian isolates of P.
aeruginosa from CF patients. On the other hand, a potential limitation of this study lies in the fact that the genetic background of the isolates was not evaluated and, thus, the origin of auxotrophic from prototrophic mutants can not be clearly defined.
Finally, we conclude that methionine was the main nutritional requirement among auxotrophic isolates and that this phenomenon was more frequently observed in P. aeruginosa recovered from sputa of CF patients indicating that this is a characteristic of this bacteria in this group of patients. 101  yes  methionine  weak  144  no  methionine  weak  146  yes  methionine  weak  165  yes  arginine  weak  178  yes  arginine  weak  197  yes  alanine and proline  weak  214  yes  asparagine  moderate  233  yes  asparagine  moderate  236  yes  methionine  weak  338  yes  methionine  moderate  340  yes  methionine  weak  342  yes  methionine  weak  345 yes methionine, cysteine and threonine weak a Classification of biofilm production determined by a microtiter plate assay according to Stepanovic et al (6) .
